Clinical trial
Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)
NCT01675661 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Achieving Cannabis Cessation: Evaluating N-Acetylcysteine Treatment (ACCENT)
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 302 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cannabis dependence